Lumanity

We are still celebrating the recent recognition that two of our staff were awarded at the 2024 British Healthcare Business Intelligence Association (BHBIA) Annual Conference. Thomas Markham, Associate Director, was presented with the 2024 Keith Munro Award for Best Presentation for his presentation, The TikTok Revolution: How video sharing platforms are redefining healthcare insights, and Yuliya Fontanetti, Global Head, Quality Assurance and Compliance, was presented with the Julie Stacey Award for Best Workshop Presenter (2021 – 2023.) Yuliya was also later named as Chair of the BHBIA Ethics and Compliance Committee. Check out videos of both Thomas and Yuliya as they share their pride in these awards and their involvement in the BHBIA and in the industry. https://buff.ly/4bsO69O #BritishHealthcare #BHBIA #BHBIA2024 #healthcareinsights #ethicsandcompliance

We are thrilled to have been shortlisted as a finalist for the 2024 Communiqué Awards in the Excellence in Communicating and Using Data category for our submission, First Consensus Recommendations for Holistic Care in Hereditary ATTR Amyloidosis. Through this project with Alnylam Pharmaceuticals, we developed the first published recommendations to recognize the value of the patient community in advocating for the needs of patients with ATTRv amyloidosis, and to call for a major shift in the current approach to its management. These recommendations were published in BMJ Open, a peer-reviewed, open access journal with wide dissemination to a global audience. The Communique Awards “recognize, reward and commend excellence and best practices in medical affairs and healthcare communications.” For more information about the awards, visit https://buff.ly/4eEprBO #CommuniqueAwards2024 #healthcarecomms #amyloidosis #medicalaffairs #patientadvocacy #ATTRv #patientcommunity

Don't miss our upcoming webinar, designed for client insight teams to hear from our experts, including Joel Shopland, Laura Galimam, Mary Stewart, and Damian Eade, as they share learnings from four of the presentations showcased during our recent internal research festival. The demand for agile and focused research insights comes against a backdrop of growing industry pressures. Staying ahead of the curve not only requires a deep understanding of the intricate interplay of market trends, competitive landscape, and patient needs, but the ability to adapt quickly to changing dynamics. Learn more and register at https://buff.ly/3XFaERf #researchinsights #markettrends #competitorlandscape #patientneeds #innovation #pharma

There's still time to register for tomorrow's webinar, Oncology 2050: Have We Been Thinking About the Management of Cancer in the Right Way? Join panelists Axel Hoos, Peter Sandor, Jeff Bockman, Viraj Parekh, and Dennis Chang as they dive into the future of oncology, redefining treatment strategies, advancing AI, and more. Register at https://buff.ly/3xla0hf #Oncology #Cancer #CancerProgress #CancerTreatment #AIinCancerTreatment

Our CEO, Jon Williams, has been named in Endpoints News’ third annual feature on LGBTQ+ leaders in biopharma. The article honors individuals shaping the future of not only their community, but also the biotechs, pharmaceutical companies and other organizations involved in making and bringing new medicines to patients. In the interview, Jon highlights the importance of advocating for LGBTQ+ rights and inclusion in the biopharma industry, highlighting that though we’ve come a long way, there is always more work to do. He also discusses creating workplace environments where everyone feels accepted, and insists on upholding these values to ensure the next generation of LGBTQ+ people working in biopharma have role models. “Every young person needs to be able to look at somebody else and say, ‘I see myself in that person, and that person is successful, and I want to be like that person.” Read the full article, including the experiences and stories from 13 other individuals named in the feature at https://buff.ly/4cDao9w. Happy Pride! #lgbtqleadership #pridemonth #lgbtqrolemodels #prideatwork

Don't miss us this week at the European Pharmaceutical Market Research Association (EPHMRA) 2024 Conference, and be sure to catch tomorrow's parallel session, Closing the gap between segmentation and real life: how AI can help to identify levers for and develop more targeted approaches, featuring Masha Eletskaya and Damian Eade. The session will focus on segmentation research and the methods available to explain the variety in human decision-making during interactions between key actors in the healthcare process. For more information, visit https://buff.ly/3x6wySv #EPHMRA2024 #EPHMRA #marketresearch #socialmediainsights #AI #artificialintelligence #decisionmaking #healthcaredecisionmaking

It's not too late to register for this week's webinar, Oncology 2050: Have We Been Thinking About the Management of Cancer in the Right Way? Join us as we dive into the future of oncology, redefining treatment strategies, advancing AI, and more. Register at https://buff.ly/4cyJjEm Hear from our panel of experts, including Axel Hoos, Peter Sandor, EVP, Astellas Pharma US, and Lumanity's Jeff Bockman, Viraj Parekh, and Dennis Chang. #Oncology #Cancer #CancerProgress #CancerTreatment #AIinCancerTreatment

We are pleased to say we have committed to setting, within 24 months, near- and long-term company-wide emission reductions in line with science-based net-zero with the Science Based Targets initiative (SBTi). This is part of our ongoing dedication to sustainable and responsible business practices. By aligning with the SBTi, we acknowledge the pressing need for climate action. The SBTi aims to limit global warming to well below 2 degrees Celsius above pre-industrial levels, with efforts to limit the increase to 1.5 degrees Celsius. Read on: https://buff.ly/4exSFlP More about science-based targets: https://buff.ly/3Xwieh5

We are still accepting submissions! Share your experiences and wisdom through a series of quick and insightful questions. In bringing your story into the spotlight, we help share information on rare diseases and support the community. Lumanity is committed to amplifying the voices of people living with a rare condition, and using our '29 stories' initiative, we seek to alleviate feelings of isolation, drive awareness for rare diseases, and facilitate more open and authentic conversations about the impact on patients and families. If you or anyone you know would like to submit a story, visit https://buff.ly/4c7nwng #rarediseases #raredisease #29stories #patientadvocacy #rarecondition #shareyourstory

June 19, 2024 commemorates the 159th anniversary of Juneteenth in the U.S. and Lumanity’s U.S. offices are closed today. Juneteenth, a combination of "June" and "19th" is also known as “Freedom Day” or “Emancipation Day.” Juneteenth commemorates the day when the last enslaved African Americans were freed from slavery in 1865. Though President Abraham Lincoln signed the Emancipation Proclamation in 1863 granting freedom to enslaved people, enslavers were responsible for telling them and many ignored the order until it was enforced by Union troops. Although it only became a national holiday in 2021, the first Juneteenth celebrations were recorded in 1866, making it one of the oldest continually celebrated holidays in the U.S. Learn more about the historical legacy of Juneteenth at https://buff.ly/4bWPWAv #Juneteenth #Juneteenth2024 #Freedomday #Emancipationday